Phase II Study of Suberoylanilide Hydroxamic Acid (SAHA) (NSC 701852) as Salvage Therapy in Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 22 Oct 2016
At a glance
- Drugs Vorinostat (Primary)
- Indications Advanced breast cancer
- Focus Biomarker; Therapeutic Use
- 07 Feb 2008 Status changed from in progress to completed.
- 02 Nov 2005 New trial record.